![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 41193 |
FusionGeneSummary for USP6NL_GPHN |
![]() |
Fusion gene information | Fusion gene name: USP6NL_GPHN | Fusion gene ID: 41193 | Hgene | Tgene | Gene symbol | USP6NL | GPHN | Gene ID | 9712 | 10243 |
Gene name | USP6 N-terminal like | gephyrin | |
Synonyms | RNTRE|TRE2NL|USP6NL-IT1 | GEPH|GPH|GPHRYN|HKPX1|MOCODC | |
Cytomap | 10p14 | 14q23.3-q24.1 | |
Type of gene | protein-coding | protein-coding | |
Description | USP6 N-terminal-like proteinrelated to the N-terminus of tre | gephyrin | |
Modification date | 20180523 | 20180523 | |
UniProtAcc | Q92738 | Q9NQX3 | |
Ensembl transtripts involved in fusion gene | ENST00000609104, ENST00000277575, ENST00000379237, ENST00000443016, ENST00000609853, | ENST00000315266, ENST00000478722, ENST00000459628, ENST00000543237, ENST00000305960, ENST00000544752, | |
Fusion gene scores | * DoF score | 17 X 12 X 9=1836 | 9 X 13 X 12=1404 |
# samples | 18 | 20 | |
** MAII score | log2(18/1836*10)=-3.35049724708413 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(20/1404*10)=-2.81147103052984 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: USP6NL [Title/Abstract] AND GPHN [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | USP6NL | GO:0043547 | positive regulation of GTPase activity | 17562788 |
Tgene | GPHN | GO:0032324 | molybdopterin cofactor biosynthetic process | 26613940 |
Tgene | GPHN | GO:0097112 | gamma-aminobutyric acid receptor clustering | 26613940 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChiTaRS3.1 | DB087988 | USP6NL | chr10 | 11639629 | - | GPHN | chr14 | 67291192 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
Frame-shift | ENST00000609104 | ENST00000315266 | USP6NL | chr10 | 11639629 | - | GPHN | chr14 | 67291192 | + |
Frame-shift | ENST00000609104 | ENST00000478722 | USP6NL | chr10 | 11639629 | - | GPHN | chr14 | 67291192 | + |
5CDS-intron | ENST00000609104 | ENST00000459628 | USP6NL | chr10 | 11639629 | - | GPHN | chr14 | 67291192 | + |
5CDS-intron | ENST00000609104 | ENST00000543237 | USP6NL | chr10 | 11639629 | - | GPHN | chr14 | 67291192 | + |
5CDS-intron | ENST00000609104 | ENST00000305960 | USP6NL | chr10 | 11639629 | - | GPHN | chr14 | 67291192 | + |
5CDS-3UTR | ENST00000609104 | ENST00000544752 | USP6NL | chr10 | 11639629 | - | GPHN | chr14 | 67291192 | + |
intron-3CDS | ENST00000277575 | ENST00000315266 | USP6NL | chr10 | 11639629 | - | GPHN | chr14 | 67291192 | + |
intron-3CDS | ENST00000277575 | ENST00000478722 | USP6NL | chr10 | 11639629 | - | GPHN | chr14 | 67291192 | + |
intron-intron | ENST00000277575 | ENST00000459628 | USP6NL | chr10 | 11639629 | - | GPHN | chr14 | 67291192 | + |
intron-intron | ENST00000277575 | ENST00000543237 | USP6NL | chr10 | 11639629 | - | GPHN | chr14 | 67291192 | + |
intron-intron | ENST00000277575 | ENST00000305960 | USP6NL | chr10 | 11639629 | - | GPHN | chr14 | 67291192 | + |
intron-3UTR | ENST00000277575 | ENST00000544752 | USP6NL | chr10 | 11639629 | - | GPHN | chr14 | 67291192 | + |
intron-3CDS | ENST00000379237 | ENST00000315266 | USP6NL | chr10 | 11639629 | - | GPHN | chr14 | 67291192 | + |
intron-3CDS | ENST00000379237 | ENST00000478722 | USP6NL | chr10 | 11639629 | - | GPHN | chr14 | 67291192 | + |
intron-intron | ENST00000379237 | ENST00000459628 | USP6NL | chr10 | 11639629 | - | GPHN | chr14 | 67291192 | + |
intron-intron | ENST00000379237 | ENST00000543237 | USP6NL | chr10 | 11639629 | - | GPHN | chr14 | 67291192 | + |
intron-intron | ENST00000379237 | ENST00000305960 | USP6NL | chr10 | 11639629 | - | GPHN | chr14 | 67291192 | + |
intron-3UTR | ENST00000379237 | ENST00000544752 | USP6NL | chr10 | 11639629 | - | GPHN | chr14 | 67291192 | + |
intron-3CDS | ENST00000443016 | ENST00000315266 | USP6NL | chr10 | 11639629 | - | GPHN | chr14 | 67291192 | + |
intron-3CDS | ENST00000443016 | ENST00000478722 | USP6NL | chr10 | 11639629 | - | GPHN | chr14 | 67291192 | + |
intron-intron | ENST00000443016 | ENST00000459628 | USP6NL | chr10 | 11639629 | - | GPHN | chr14 | 67291192 | + |
intron-intron | ENST00000443016 | ENST00000543237 | USP6NL | chr10 | 11639629 | - | GPHN | chr14 | 67291192 | + |
intron-intron | ENST00000443016 | ENST00000305960 | USP6NL | chr10 | 11639629 | - | GPHN | chr14 | 67291192 | + |
intron-3UTR | ENST00000443016 | ENST00000544752 | USP6NL | chr10 | 11639629 | - | GPHN | chr14 | 67291192 | + |
intron-3CDS | ENST00000609853 | ENST00000315266 | USP6NL | chr10 | 11639629 | - | GPHN | chr14 | 67291192 | + |
intron-3CDS | ENST00000609853 | ENST00000478722 | USP6NL | chr10 | 11639629 | - | GPHN | chr14 | 67291192 | + |
intron-intron | ENST00000609853 | ENST00000459628 | USP6NL | chr10 | 11639629 | - | GPHN | chr14 | 67291192 | + |
intron-intron | ENST00000609853 | ENST00000543237 | USP6NL | chr10 | 11639629 | - | GPHN | chr14 | 67291192 | + |
intron-intron | ENST00000609853 | ENST00000305960 | USP6NL | chr10 | 11639629 | - | GPHN | chr14 | 67291192 | + |
intron-3UTR | ENST00000609853 | ENST00000544752 | USP6NL | chr10 | 11639629 | - | GPHN | chr14 | 67291192 | + |
Top |
FusionProtFeatures for USP6NL_GPHN |
![]() |
Hgene | Tgene |
USP6NL | GPHN |
Acts as a GTPase-activating protein for RAB5A and RAB43.Involved in receptor trafficking. In complex with EPS8 inhibitsinternalization of EGFR. Involved in retrograde transport from theendocytic pathway to the Golgi apparatus. Involved in thetransport of Shiga toxin from early and recycling endosomes to thetrans-Golgi network. Required for structural integrity of theGolgi complex. {ECO:0000269|PubMed:11099046,ECO:0000269|PubMed:17562788, ECO:0000269|PubMed:17684057}. | Microtubule-associated protein involved in membraneprotein-cytoskeleton interactions. It is thought to anchor theinhibitory glycine receptor (GLYR) to subsynaptic microtubules.Catalyzes two steps in the biosynthesis of the molybdenumcofactor. In the first step, molybdopterin is adenylated.Subsequently, molybdate is inserted into adenylated molybdopterinand AMP is released. {ECO:0000269|PubMed:26613940}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for USP6NL_GPHN |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for USP6NL_GPHN |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
USP6NL | ACTN4, GRB2, APP, WWOX, SHMT2, NXF1, TMEM17, CCNA2, COMT, ANAPC15, UBE2S, CDH1 | GPHN | ARHGEF9, GLRB, MTOR, PFN1, OTUD4, PRPF4, PCK1, SPATS1, GPHN, KHDRBS1, ACADVL, BRCC3, MTA2, PAAF1, PPP4R1, ROCK2, SPTAN1, TSSK1B, ODF3L2, NTRK1, DYNLL1, CDCA5, TCF4, SENP3, VASP, ENAH, KLKB1, KMO, LGALS3BP, STS, DYNLL2 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for USP6NL_GPHN |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for USP6NL_GPHN |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | USP6NL | C0025202 | melanoma | 1 | CTD_human |
Tgene | GPHN | C0001973 | Alcoholic Intoxication, Chronic | 1 | CTD_human |
Tgene | GPHN | C0236736 | Cocaine-Related Disorders | 1 | CTD_human |
Tgene | GPHN | C1854990 | Molybdenum Cofactor Deficiency, Complementation Group C | 1 | ORPHANET;UNIPROT |